Ariston Pharma Nova Tech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-05-2024
- Paid Up Capital ₹ 6.70 M
as on 07-05-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 6.09 Cr
as on 07-05-2024
- Revenue -46.56%
(FY 2019)
- Profit -75.75%
(FY 2019)
- Ebitda -21.30%
(FY 2019)
- Net Worth 3.26%
(FY 2019)
- Total Assets -3.78%
(FY 2019)
About Ariston Pharma Nova Tech
- CIN/LLPIN
U24232TG2012PTC083734
- Company No.
083734
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ariston Pharma Nova Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vedprakash Vyas  | Director | 19-Oct-2012 | Current |
| Subhash Bissa | Director | 25-Sep-2019 | Current |
Financial Performance of Ariston Pharma Nova Tech.
Ariston Pharma Nova Tech Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 46.56% decrease. The company also saw a substantial fall in profitability, with a 75.75% decrease in profit. The company's net worth moved up by a moderate rise of 3.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ariston Pharma Nova Tech?
In 2019, Ariston Pharma Nova Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 28 Mar 2017 | ₹0.94 M | Open |
Syndicate Bank Creation Date: 09 Nov 2015 | ₹6.00 Cr | Open |
How Many Employees Work at Ariston Pharma Nova Tech?
Ariston Pharma Nova Tech has a workforce of 24 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ariston Pharma Nova Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ariston Pharma Nova Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
